Market Tracker

09/22 3:55am ET

Impax Laboratories Inc (NASDAQ:IPXL)

24.53
Data as of Sep 19
 -0.72 / -2.85%
Today’s Change
19.39
Today|||52-Week Range
31.04
-2.43%
Year-to-Date

Today’s Trading

Previous close25.25
Today’s open25.33
Day’s range24.33 - 25.58
Volume1,080,848
Average volume (3 months)699,122
Market cap$1.7B
Dividend yield--
Data as of 3:59pm ET, 09/19/2014

Growth & Valuation

Earnings growth (last year)+79.27%
Earnings growth (this year)+41.42%
Earnings growth (next 5 years)+26.24%
Revenue growth (last year)-12.07%
P/E ratio1,226.5
Price/Sales3.29
Price/Book2.11

Competitors

 Today’s
change
Today’s
% change
RAREUltragenyx Pharmaceu...-0.97-1.74%
RCPTReceptos Inc+1.63+2.62%
IRWDIronwood Pharmaceuti...-0.25-1.95%
GWPHGW Pharmaceuticals P...-1.18-1.34%
Data as of 3:59pm ET, 09/19/2014

Financials

Next reporting dateNovember 4, 2014
EPS forecast (this quarter)$0.31
Annual revenue (last year)$511.5M
Annual profit (last year)$101.3M
Net profit margin19.80%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President &
Chief Executive Officer
George Frederick Wilkinson
Chief Financial Officer &
Senior VP-Finance
Bryan M. Reasons
Corporate headquarters
Hayward, California

Forecasts